Prediction of initial objective response to drug-eluting beads transcatheter arterial chemoembolization for hepatocellular carcinoma using CT radiomics-based machine learning model

被引:4
|
作者
Zhang, Xueying [1 ]
He, Zijun [1 ]
Zhang, Yucong [2 ]
Kong, Jian [3 ]
机构
[1] Jinan Univ, Clin Med Coll 2, Shenzhen, Guangdong, Peoples R China
[2] Southern Univ Sci & Technol, Jinan Univ, Shenzhen Peoples Hosp,Clin Med Coll 2, Dept Radiat Oncol,Affiliated Hosp 1, Shenzhen, Guangdong, Peoples R China
[3] Southern Univ Sci & Technol, Jinan Univ, Shenzhen Peoples Hosp,Affiliated Hosp 1, Dept Intervent Radiol,Clin Med Coll 2, Shenzhen, Guangdong, Peoples R China
关键词
hepatocellular carcinoma; drug-eluting beads transcatheter arterial chemoembolization; initial response; objective response; computed tomography; radiomics; nomogram; prediction; TRANSARTERIAL CHEMOEMBOLIZATION; LIVER-CANCER; TIME-POINT; DC BEAD; MRECIST; CLASSIFICATION; SURVIVAL; HETEROGENEITY; SYSTEM; EASL;
D O I
10.3389/fphar.2024.1315732
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: A prognostic model utilizing CT radiomics, radiological, and clinical features was developed and validated in this study to predict an objective response to initial transcatheter arterial chemoembolization with drug-eluting beads (DEB-TACE) for hepatocellular carcinoma (HCC).Methods: Between January 2017 and December 2022, the baseline clinical characteristics and preoperative and postoperative follow-up imaging data of 108 HCC patients who underwent the first time treatment of DEB-TACE were analyzed retrospectively. The training group (n = 86) and the validation group (n = 22) were randomly assigned in an 8:2 ratio. By logistic regression in machine learning, radiomics, and clinical-radiological models were constructed separately. Finally, the integrated model construction involved the integration of both radiomics and clinical-radiological signatures. The study compared the integrated model with radiomics and clinical-radiological models using calibration curves, receiver operating characteristic (ROC) curves, and decision curve analysis (DCA).Results: The objective response rate observed in a group of 108 HCC patients who received initial DEB-TACE treatment was found to be 51.9%. Among the three models, the integrated model exhibited superior predictive accuracy in both the training and validation groups. The training group resulted in an area under the curve (AUC) of 0.860, along with sensitivity and specificity values of 0.650 and 0.913, respectively. Based on the findings from the validation group, the AUC was estimated to be 0.927. Additionally, it was found that values of sensitivity and specificity were 0.875 and 0.833, respectively. In the validation group, the AUC of the integrated model showed a significant improvement when contrasted to the clinical-radiological model (p = 0.042). Nevertheless, no significant distinction was observed in the AUC when comparing the integrated model with the radiomics model (p = 0.734). The DCA suggested that the integrated model demonstrates advantageous clinical utility.Conclusion: The integrated model, which combines the CT radiomics signature and the clinical-radiological signature, exhibited higher predictive efficacy than either the radiomics or clinical-radiological models alone. This suggests that during the prediction of the objective responsiveness of HCC patients to the first DEB-TACE treatment, the integrated model yields superior outcomes.
引用
收藏
页数:17
相关论文
共 50 条
  • [21] MRI Findings and Prediction of Time to Progression of Patients with Hepatocellular Carcinoma Treated with Drug-eluting Bead Transcatheter Arterial Chemoembolization
    Lee, Seungsoo
    Kim, Kyung Ah
    Park, Mi-Suk
    Choi, Sun Young
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2015, 30 (07) : 965 - 973
  • [22] Enhancement Patterns of Hepatocellular Carcinoma After Transarterial Chemoembolization Using Drug-Eluting Beads on Arterial Phase CT Images: A Pilot Retrospective Study
    Chung, Woo-Suk
    Lee, Kwang-Hun
    Park, Mi-Suk
    Lee, Yeo Jin
    Kwon, Joonho
    Baek, Song-Ee
    Kim, Myeong-Jin
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2012, 199 (02) : 349 - 359
  • [23] Five-year outcome of conventional and drug-eluting transcatheter arterial chemoembolization in patients with hepatocellular carcinoma
    Yi-Sheng Liu
    Chia-Ying Lin
    Ming-Tsung Chuang
    Chia-Ying Lin
    Yi-Shan Tsai
    Chien-Kuo Wang
    Ming-Ching Ou
    BMC Gastroenterology, 18
  • [24] Five-year outcome of conventional and drug-eluting transcatheter arterial chemoembolization in patients with hepatocellular carcinoma
    Liu, Yi-Sheng
    Lin, Chia-Ying
    Chuang, Ming-Tsung
    Tsai, Yi-Shan
    Wang, Chien-Kuo
    Ou, Ming-Ching
    BMC GASTROENTEROLOGY, 2018, 18
  • [25] Early response of treatment to hepatocellular carcinoma using transarterial chemoembolization with drug eluting beads
    Hoang Dong Duc
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 167 - 167
  • [26] Evaluation of drug-eluting beads versus conventional transcatheter arterial chemoembolization in patients with unresectable hepatocellular carcinoma: A systematic review and meta-analysis
    Chen, Peng
    Yuan, Peng
    Chen, Bo
    Sun, Jingchang
    Shen, Hang
    Qian, Yeben
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2017, 41 (01) : 75 - 85
  • [27] Predictive factors for complete response of chemoembolization with drug-eluting beads (DEB-TACE) for hepatocellular carcinoma
    Guillaume Vesselle
    Camille Quirier-Leleu
    Stéphane Velasco
    Florian Charier
    Christine Silvain
    Samy Boucebci
    Pierre Ingrand
    Jean-Pierre Tasu
    European Radiology, 2016, 26 : 1640 - 1648
  • [28] Predictive factors for complete response of chemoembolization with drug-eluting beads (DEB-TACE) for hepatocellular carcinoma
    Vesselle, Guillaume
    Quirier-Leleu, Camille
    Velasco, Stephane
    Charier, Florian
    Silvain, Christine
    Boucebci, Samy
    Ingrand, Pierre
    Tasu, Jean-Pierre
    EUROPEAN RADIOLOGY, 2016, 26 (06) : 1640 - 1648
  • [29] Tumor Response and Nomogram-Based Prognostic Stratification for Hepatocellular Carcinoma After Drug-Eluting Beads Transarterial Chemoembolization
    Ji, Kun
    Zhu, Hanlong
    Wu, Wei
    Li, Xin
    Zhan, Pengchao
    Shi, Yang
    Sun, Junhui
    Li, Zhen
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2022, 9 : 537 - 551
  • [30] Hepatocellular carcinoma: initial tumour response after short-term and long-interval chemoembolization with drug-eluting beads using modified RECIST
    Syha, Roland
    Ketelsen, Dominik
    Heller, Stefan
    Schmehl, Joerg
    Mangold, Stefanie
    Heuschmid, Martin
    Springer, Fabian
    Claussen, Claus D.
    Brechtel, Klaus
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2012, 24 (11) : 1325 - 1332